SCHEDULE 13G

Company

Phio Pharmaceuticals Corp.

Filed

April 18, 2018

Accession Number

0001213900-18-004648

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →